CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- 4 Shares withheld for taxes EVP and General Counsel gave up 11,179 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 10,659 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 701 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,090 shares (to pay taxes)
- 4 Open-market sale EVP & Chief Commercial Officer sold 5,693 shares at $18.33 ($104,353)
- 4 Shares withheld for taxes EVP and General Counsel gave up 734 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Technical Officer gave up 1,386 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,386 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Commercial Officer gave up 595 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,394 shares (to pay taxes)
- 4 Open-market sale President and CEO sold 22,066 shares at an average $23.09 ($509,602)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award Director acquired 9,941 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 42,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 8 of 21 · 415 filings